Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Inventory Average (2017 - 2025)

Historic Inventory Average for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $9.0 million.

  • Puma Biotechnology's Inventory Average rose 5412.9% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 5412.9%. This contributed to the annual value of $7.9 million for FY2024, which is 3617.09% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Inventory Average is $9.0 million, which was up 5412.9% from $8.7 million recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Inventory Average peaked at $9.0 million during Q3 2025, and registered a low of $4.2 million during Q1 2023.
  • For the 5-year period, Puma Biotechnology's Inventory Average averaged around $6.8 million, with its median value being $7.0 million (2022).
  • As far as peak fluctuations go, Puma Biotechnology's Inventory Average soared by 14830.32% in 2021, and later tumbled by 4149.17% in 2023.
  • Quarter analysis of 5 years shows Puma Biotechnology's Inventory Average stood at $7.2 million in 2021, then plummeted by 30.3% to $5.0 million in 2022, then increased by 27.87% to $6.4 million in 2023, then fell by 10.67% to $5.7 million in 2024, then soared by 58.52% to $9.0 million in 2025.
  • Its Inventory Average stands at $9.0 million for Q3 2025, versus $8.7 million for Q2 2025 and $8.7 million for Q1 2025.